as on February 6, 2026 at 9:31 pm IST
52 Week's Low
52 Week's High
7.32%
Downside
43.41%
Upside
as on February 6, 2026 at 4:01 pm IST
Market Cap
₹8.20 Cr
Return on Equity (ROE)
-16.02
PE Ratio (TTM)
-25.62
Return on capital employed (ROCE)
-3.87
Industry PE ratio
40.88
Beta (LTM)
-0.03
P/B Ratio
1.97
Dividend Yield
0PEG Ratio
256.25
Quarterly Earnings Growth YOY
2700
EPS (TTM)
-0.17
Sector
Pharmaceuticals
Book Value
0.99
as on February 6, 2026 at 4:01 pm IST
Vivanza Biosciences in the last 5 years
Lowest (-15423.93x)
December 21, 2022
Today (-25.62x)
February 6, 2026
Industry (40.88x)
February 6, 2026
Highest (884.71x)
July 19, 2023
Today’s Price to Earnings Ratio: -25.62x
Compare market cap, revenue, PE, and other key metrics of Vivanza Biosciences with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 8.20 | -17.64% | 0.84 | -1 | 7 | |
| BUY | 7,137.23 | -0.09% | 0.00 | 135 | 498 | |
| NA | 342.83 | 39.54% | 0.69 | 7 | 155 | |
| NA | 2.89 | -13.17% | 0.65 | NA | 18 | |
| NA | 63.18 | -9.84% | 0.71 | 7 | 46 |
Get share price movements and forecasts by analysts on Vivanza Biosciences.
Source: S&P Global Market Intelligence
Search interest for Vivanza Biosciences Ltd Stock has decreased by -4% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Vivanza Biosciences.
Vivanza Biosciences Ltd’s net profit jumped 2700% since last year same period to ₹0.56Cr in the Q2 2025-2026. On a quarterly growth basis, Vivanza Biosciences Ltd has generated 522.22% jump in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 3 quarters, -1.0 Cr → 0.56 Cr (in ₹), with an average increase of 647.5% per quarter
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 0.53 Cr → 55.37 Cr (in ₹), with an average increase of 89.0% per quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 20.02% of holdings in Dec 2025 quarter
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 79.98% of holdings in Dec 2025 quarter
Price Dip
![]()
In the last 7 days, Vivanza Biosci. stock has moved down by -5.1%
| Organisation | Vivanza Biosciences Ltd |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Vivanza Biosciences share price today stands at ₹2.05 as on at the close of the market. Vivanza Biosciences share today touched a day high of ₹2.05 and a low of ₹2.05.
Vivanza Biosciences touched a 52 week high of ₹2.94 and a 52 week low of ₹1.9. Vivanza Biosciences share price today i.e. is closed at ₹2.05, which is -30.27% down from its 52 week high and 7.89% up from its 52 week low.
Vivanza Biosciences market capitalisation is ₹8.20 Cr as on .
To buy Vivanza Biosciences shares, you need to follow these steps:
Vivanza Biosciences trading volume is 4,085.00 as on . This means that 4,085.00 shares of Vivanza Biosciences were bought and sold on the stock market during today's trading session.